Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation

article by Sylvie Pelletier et al published June 2016 in Genetics in Medicine

Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/GIM.2015.135
P2888exact matchhttps://scigraph.springernature.com/pub.10.1038/gim.2015.135
P698PubMed publication ID26540155

P50authorPavel HametQ3372940
William David FoulkesQ37829195
Jacques SimardQ64516110
P2093author name stringMichel Dorval
Jocelyne Chiquette
Sylvie Pelletier
Nora Wong
Zaki El Haffaf
P2860cites workAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesQ24531993
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysisQ24628361
Recommendations on screening for breast cancer in average-risk women aged 40-74 yearsQ24633913
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancerQ28203101
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statementQ28265041
BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experienceQ33576901
Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening testsQ34682487
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerQ34736112
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and QuebecQ34873841
Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family RegistryQ35609710
Falling through the cracks. Women's experiences of ineligibility for genetic testing for risk of breast cancerQ36282425
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-upQ36610024
Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic CounselorsQ36824748
Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative studyQ37312028
From candidate gene studies to GWAS and post-GWAS analyses in breast cancerQ38366358
Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 familiesQ39480009
Making decisions about cancer screening when the guidelines are unclear or conflictingQ39576818
Rigour and qualitative researchQ40445898
Qualitative research: standards, challenges, and guidelinesQ42657344
"I have always believed I was at high risk..." The role of expectation in emotional responses to the receipt of an average, moderate or high cancer genetic risk assessment result: a thematic analysis of free-text questionnaire comments.Q44436660
Cancer risk comparative perception and overscreening behaviours of non-carriers from BRCA1/2 familiesQ44568691
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.Q46520947
[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].Q49316774
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.Q51726517
A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing.Q52574933
Breast Cancer Risk for Noncarriers of Family-SpecificBRCA1andBRCA2Mutations: More Trouble With PhenocopiesQ57266555
The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancerQ81571149
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?Q82660651
Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive familiesQ84785212
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
P304page(s)627-34
P577publication date2016-06-01
P1433published inGenetics in MedicineQ15765508
P1476titleClinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation
P478volume18

Reverse relations

cites work (P2860)
Q51554509Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?
Q47154249No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families

Search more.